A detailed history of Charles Schwab Investment Management Inc transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 26,689 shares of LIFE stock, worth $49,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,689
Previous 26,689 -0.0%
Holding current value
$49,641
Previous $41,000 19.51%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$1.88 - $2.5 $31,375 - $41,722
16,689 Added 166.89%
26,689 $56,000
Q4 2021

Feb 11, 2022

BUY
$7.29 - $9.5 $72,900 - $95,000
10,000 New
10,000 $75,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.